GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Operating Cash Flow per Share

Longevity Biomedical (Longevity Biomedical) Operating Cash Flow per Share : $ (TTM As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Operating Cash Flow per Share?

Longevity Biomedical's operating cash flow per share for the six months ended in . 20 was $0.00. Longevity Biomedical does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Longevity Biomedical's Operating Cash Flow per Share or its related term are showing as below:

LBIO's 3-Year OCF Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Longevity Biomedical Operating Cash Flow per Share Historical Data

The historical data trend for Longevity Biomedical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Operating Cash Flow per Share Chart

Longevity Biomedical Annual Data
Trend
Operating Cash Flow per Share

Longevity Biomedical Semi-Annual Data
Operating Cash Flow per Share

Competitive Comparison of Longevity Biomedical's Operating Cash Flow per Share

For the Biotechnology subindustry, Longevity Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Price-to-Operating-Cash-Flow falls into.



Longevity Biomedical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Longevity Biomedical's Operating Cash Flow per Share for the fiscal year that ended in . 20 is calculated as

Operating Cash Flow per Share (A: . 20 )=Cash Flow from Operations (A: . 20 )/Shares Outstanding (Diluted Average) (A: . 20 )
=/0
=

Longevity Biomedical's Operating Cash Flow per Share for the quarter that ended in . 20 is calculated as

Operating Cash Flow per Share (Q: . 20 )=Cash Flow from Operations (Q: . 20 )/Shares Outstanding (Diluted Average) (Q: . 20 )
=/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines